Worldwide, prostate cancer holds the title of the second most frequently diagnosed cancer in males; however, many men suffering from this condition are completely unaware of it until it is in advanced stages. This happens because, while the body does give out signals, those signals are often misattributed to other conditions, especially among older men, who may think that any urinary changes they experience are just due to ageing.

Key Takeaways

● Prostate cancer in its early stages rarely causes dramatic symptoms. The changes that do appear are subtle and frequently mistaken for benign prostate enlargement.

Gold Rate

July 23 ,2026 - Time 10.30Hrs

Gold 24 KT ₹ 1 45,900 /-

Gold 22 KT ₹ 1,35,400 /-

Silver/Kg ₹ 2,27,000/-

Platinum ₹ 88,000/-

Recommended rate for Nagpur sarafa Making charges minimum 13% and above

● PSA testing alongside clinical examination provides the most accessible screening pathway currently available for men at average and elevated risk.

● Age, family history, and ethnicity are the three strongest risk factors that should prompt earlier and more regular monitoring.

● Advanced prostate cancer is now manageable over the long term with modern hormonal agents that have significantly extended survival outcomes.

What Prostate Cancer Is and Why Timing Matters

The prostate is a small organ that lies just below the bladder and wraps around the urethra. This organ produces secretions that are a constituent of semen. Cancer originates in the cells of the organ and usually takes the form of a slow-growing adenocarcinoma. The cancer in this form may take several years to spread beyond the prostate capsule. In certain individuals with aggressive types of cancer, the growth and metastasis of the disease occur more quickly.

The timing becomes important in this case. When cancer remains confined to the prostate, it can be successfully treated and sometimes even cured. However, when it spreads to lymph nodes, bones or distant organs, treatment is aimed at long-term control rather than achieving a cure.

What the Early Signs Actually Look Like

In the earliest stages of prostate cancer, symptoms are usually similar to those of benign prostatic hyperplasia, a non-cancerous enlargement of the prostate. This is one of the main reasons why cancer is frequently undetected in its early stages.

Symptoms that may appear and should prompt medical evaluation include:

A weak or interrupted urinary stream that has changed from the individual’s normal pattern
Increased frequency of urination, particularly at night
Difficulty initiating urination despite urgency
A feeling that the bladder has not fully emptied after urinating
Blood in the urine or semen, which is less common but more directly suggestive of pathology
Discomfort in pelvic region or pain in the lower back, hips, or upper thighs, which more often appears in later disease

Risk Factors That Should Prompt Earlier Screening

Age is the single strongest factor, with the majority of cases occurring in men over 65
Family history, particularly a first-degree relative diagnosed before age 65, doubles or triples individual risk
Black African and Black Caribbean ethnicity is associated with higher incidence and more aggressive disease
BRCA2 gene mutations significantly elevate lifetime risk and are associated with more aggressive tumour biology

Men with any of these risk factors should discuss prostate-specific antigen testing with their doctor earlier than the general population, typically from age 40 to 45 rather than waiting until 50.

How Prostate Cancer Is Diagnosed

The first step in the diagnosis of prostate cancer is the clinical evaluation, which uses the PSA blood test and the digital rectal exam. An increased PSA does not indicate the presence of cancer by itself, but necessitates further examination. Multiparametric MRI of the prostate has become the norm for pre-biopsy diagnosis, as it enables targeted sampling of possible diseased areas instead of random biopsy. The biopsy results are graded taking into account the Gleason score and Grade Group.

Once cancer has been confirmed, it is important to carry out further examinations using a CT scan, a bone scan, or PSMA PET to determine whether it has spread beyond the prostate.

Prostate Cancer Treatment Options by Stage

Treatment of prostate cancer takes into account the grade and stage of cancer. For patients with localised low-risk cancer, active surveillance is a good treatment option as it avoids overtreatment while ensuring that the patients are closely monitored. For localised high-risk and intermediate-risk cases, one can apply radical prostatectomy and radiotherapy with or without the use of androgen deprivation therapy.

Among patients with locally advanced or metastatic disease, systemic hormonal therapy is the leading form of treatment. When the disease becomes castration-resistant, meaning it progresses despite the low level of testosterone, new medicines that provide more complete androgen signalling blockade are used. The use of abiraterone acetate, a CYP17A1 inhibitor, can provide such blockade since, by blocking androgen synthesis, it ensures a higher level of androgen suppression compared to standard hormonal therapy.

While Zytiga is the original branded medicine containing abiraterone acetate, it is given with a lower-than-therapeutic dose of prednisolone to mitigate mineralocorticoid adverse reactions. Conversely, Abirapro, a generic version made available for the same medicine in India, offers the same mode of action at a much lower price, benefiting patients living with a chronic condition needing long-term therapy.

Managing Side Effects During Treatment

Hormonal therapy for advanced prostate cancer carries a characteristic set of side effects that require proactive management:

Hot flushes and night sweats from androgen deprivation
Fatigue and reduced physical stamina
Bone density loss requiring calcium, vitamin D supplementation, and in some patients bisphosphonate therapy
Cardiovascular risk amplification with long-term hormonal therapy
Hypertension and hypokalaemia specific to abiraterone-based treatment, monitored through regular blood tests

Emotional and Mental Health During Recovery

Diagnosis of prostate cancer affects men differently according to their ages, marital status, and the treatment they receive. Worries about sexual function, urinary control, and issues related to masculinity can frequently appear and should be addressed openly along with medical treatment interventions. Nowadays, most cancer treatment centres offer support groups for prostate cancer patients and the services of oncology psychologists to help men and their partners cope with such challenges.

Importance of Follow-Up Care

Consistent PSA evaluation following the conclusion or initiation of treatment helps detect the earliest signs of treatment success or disease relapse. When the patient is under active monitoring, regular MRIs and biopsies are crucial to detect any development as soon as possible so that the time allowed for effective treatment is not missed.

What Is Worth Remembering

Most men diagnosed with prostate cancer are usually healthy and feel good when the cancer is first detected. Early symptoms are often misinterpreted, and without adequate screening for those at risk, diagnosis typically comes later than it should. Different patients may benefit from consulting their health care professional about the meaning of a PSA test, the relevance of changes in urination, and the importance of having a family history of prostate cancer in promoting early diagnosis.

Disclaimer: This article is for general informational purposes only and should not be considered medical advice. Always consult a qualified urologist or oncologist for diagnosis, staging, treatment planning, and guidance specific to your condition.